Clarivate for Life Sciences & Healthcare

Heidelberg Pharma AG, first in the world to develop amanitin for cancer therapy, is one of the seven innovative companies listed in the Clarivate Companies to Watch report this year. Heidelberg Pharma AG uses its proprietary ADC payload (ATAC® technology) to develop ADCs called ATACs that have amanitin-based compounds as the payload.     Why is Heidelberg Pharma AG a company to watch?  Download the report to discover innovations transforming drug discovery and development, revolutionizing cancer treatment, and capturing big pharma interest, here: https://lnkd.in/eCSaAWtu #oncology #cancertreatement #biotech #pharma #companiestowatch 

Thank you for connecting with us at the Clarivate Conference 2024, held on July 4th in Tokyo, Japan. Despite the extreme heat, this annual signature event drew an impressive and highly engaged crowd from the Life Sciences & Healthcare sectors. AI's integration into life sciences holds immense potential, from drug discovery and personalized medicine to predictive analytics in healthcare. However, it also presents challenges, prompting regulatory bodies to establish guidelines addressing ethical concerns, interpretability, and more. Dr. Teruki Honma from RIKEN, Hideyoshi Fuji from Iktos, Justin Hubbard, and Akira Mori shared valuable insights on how AI is accelerating drug discovery and development. Their discussions highlighted upcoming trends and the transformative impact of AI on the pharmaceutical industry. To learn more about Clarivate's AI intelligence, products, and services, please contact us at [email protected] or visit clarivate.com/ja. #AI #DrugDevelopment #PharmaceuticalInnovation

AI-driven diagnostics are revolutionizing medical imaging, impressing with their accurate interpretations of medical images. These and similar diagnostics, powered by advanced machine learning algorithms, have garnered widespread acclaim, with numerous FDA approvals, particularly in radiology. Still, manufacturers integrating AI into their diagnostics products face significant hurdles they must jump to become a presence in the market. Read more: https://lnkd.in/eFrBgV9g #AI #Diagnostics #Blog

In MedTech, numerous technologies are enhancing preventative healthcare and improving patient outcomes while reducing the burden on healthcare systems, both in terms of costs and resources. Smart wearables, remote monitoring and AI technologies could drive behavioral changes among potential future patients, giving them a more active role in monitoring and tracking their health. In the latest Intelligent Health.tech article, April Chan-Tsui, Director, Product Operations, MedTech Insights, Clarivate discussed the MedTech opportunities and challenges that are poised to transform preventative healthcare. Read the article, here: https://lnkd.in/dBVkV9tg #AI #preventativehealthcare #MedTech #medicaldevices #smartwearables

Pharmaceutical companies like Eli Lilly and Pfizer are launching new biotech incubator programs in San Diego. This development offers significant opportunities for local startups to engage with industry experts and access potential financing. In a new article by Natallie R. of the The San Diego Union-Tribune Tribune, Rachael Craig and Mike Ward of Clarivate discuss why partnerships continue to play a critical role within the pharmaceutical industry and the importance of collaboration in fostering innovation and accelerating the development of new therapies. Read more to learn the potential implications for the San Diego biotech community: https://lnkd.in/eufny3Cr #Biotech #Pharma #Startups #SanDiego #Innovation #Partnerships #EliLilly #Pfizer

Unanticipated preclinical toxicity and adverse events in the clinical stage are leading causes of drug attrition, directly contributing to the rapidly increasing costs of drug development with potential patient safety risks. Clarivate experts highlight approaches companies can employ to identify potential safety signals early on in the drug discovery and development process. Download the report, here: https://lnkd.in/ec2Jg7jW #patientsafety #drugdevelopment #drugsafety

There is a vibrant cycle of innovation in MedTech, from the advent of groundbreaking technologies such as pulsed-field ablation to advances in diabetes care and surgical robotics. However, this progress is intertwined with significant challenges, including financial uncertainties, regulatory shifts and supply chain vulnerabilities. The new MedTech Trends to Watch report explores how this resilient industry is navigating these complexities and seizing emerging opportunities, to not just to recover, but to redefine the future of healthcare. Read more:https://lnkd.in/exM6E_X7 #MedicalTechnologiesToWatch #Medtech #MedicalTechnology

Araris Biotech AG, with its proprietary conjugation technology and linker-payload platforms to efficiently develop and advance next-generation ADCs, is one of the seven innovative companies listed in the Clarivate Companies to Watch report this year. Araris' drug attachment is simple, site-specific and has the potential to stably accommodate various drug-load combinations without altering the pharmacokinetic profile of the antibody, resulting in ADCs with a high therapeutic window. Why is Araris Biotech a company to watch?      Download the report to discover innovations transforming drug discovery and development, revolutionizing cancer treatment, and capturing big pharma interest, here: https://lnkd.in/eCSaAWtu #oncology #cancertreatement #biotech #pharma #companiestowatch

Clarivate identifies six breakthrough MedTech trends in 2024: shifts in sites of service, the impact of GLP-1 receptor agonists, deals in MedTech, supply chain, AI in MedTech and regulatory changes in Mainland China. The report is the second installment in a two-part series offering a predictive analysis of emerging trends shaping the MedTech industry. "Amidst a period of unprecedented change, the MedTech industry has demonstrated remarkable resilience and innovation. From the advent of groundbreaking technologies like pulsed field ablation to advancements in diabetes care and surgical robotics, there is a vibrant cycle of innovation," said Juliane Ray, Vice President, MedTech Strategy, Life Sciences & Healthcare, Clarivate. Highlighting both challenges—such as economic uncertainty, regulatory shifts, and fragile supply chains—and opportunities like the rise of ambulatory surgical centers and AI in MedTech, the report provides a comprehensive outlook on the industry trajectory. Learn more: https://lnkd.in/e-xHWQxA #MedtechTrendsToWatch #MedicalDevices #Medtech

The digital health research landscape is experiencing a golden age. In recent years, investors have shown significant interest in digital health start-ups, pouring substantial funding – £31 billion in 2021 and £21 billion in 2022 – into this sector. However, for university researchers accustomed to focusing on publications and long-term projects, navigating this fast-paced ecosystem can be challenging. How can these researchers actively contribute to the digital health revolution and leverage its potential benefits for public health? Read the blog, here: https://lnkd.in/eHcyqtwg #digitalhealth #investment #patent